SCHEMBL15416293

SCHEMBL15416293

FC1(F)CCCCN1c1ncccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
CYP2D6 P10635 6/20 0.36
CYP3A4 P08684 4/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 7/20 0.36
HSD17B10 Q99714 5/20 0.36
CYP1A2 P05177 4/20 0.36
USP2 O75604 2/20 0.36
HPGD P15428 2/20 0.36
ALOX15 P16050 1/20 0.35
KCNA5 P22460 3/20 0.34
KDM4E B2RXH2 2/20 0.34
KCNE1 P15382 1/20 0.34
POLB P06746 1/20 0.34
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9831419 0.70 GRIN1 (0.36) GRIN1GRIN2AGRIN2BCYP2D6CYP3A4
SCHEMBL1823832 0.67
SCHEMBL23107924 0.67 ALDH1A1 (0.44) GRIN1GRIN2AGRIN2BCYP2D6CYP3A4
SCHEMBL30079990 0.65 CYP3A4 (0.56) CYP2D6CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL18228600 0.65 KDM4E (0.60) CYP2D6CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL3339822 0.65 KDM4E (0.60) CYP2D6CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL15319234 0.64 ALDH1A1 (0.46) ALDH1A1HSD17B10USP2ALOX15KDM4E
SCHEMBL14938513 0.64
SCHEMBL14938514 0.64
SCHEMBL3609275 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872511-A1 IMIDAZOPYRAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB Biopharma SPRL (BE) 2015-05-20 EP disclosed
WO-2014009296-A1 IMIDAZOPYRAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB PHARMA S.A. (BE) 2014-01-16 WO disclosed